
Janssen Biotech Ordered to Turn Over Privileged Info Shared With Consultants, Judge Rules
A federal judge in Massachusetts shot down Janssen Biotech's attempts to limit discovery in a qui tam action, concluding that communications between employees and attorneys didn't bar the pharmaceutical company from having to turn over hundreds of …